Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2025
Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysisYuma Waseda, Wei Chen, Minato Yokoyama, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumabShumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, et al.
IJU Case Reports|November 7, 2022
Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinomaYoshitomo Yamaguchi, Minato Yokoyama, Akira Takemoto, et al.
IJU Case Reports|July 5, 2024
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinomaMotohiro Fujiwara, Wataru Shimada, Minato Yokoyama, et al.
IJU Case Reports|September 3, 2024
A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumabHiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, et al.
Anticancer Research|September 26, 2025
Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing SurgeryShunya Matsumoto, Yuma Waseda, Masaki Kobayashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2024
Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsiesYuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, et al.
Japanese Journal of Clinical Oncology|January 11, 2023
The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinomaToshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, et al.
Journal for Immunotherapy of Cancer|February 19, 2021
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumabShohei Fukuda, Kazutaka Saito, Yosuke Yasuda, et al.
Anti-Cancer Drugs|August 3, 2020
Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary reportHiroshi Fukushima, Shohei Fukuda, Shingo Moriyama, et al.
Pageof 8